BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Antinuclear Antibody Test Market Size to Reach USD 3.44 Billion in 2028, Says Reports and Data

  Rising adoption of antinuclear antibody tests owing to increasing prevalence of autoimmune diseases is a major factor supporting market revenue growth.

  June 16, 2021

   · 

  5 min read
• Digital Radiography Market Size to Reach USD 19.82 Billion in 2028, Says Reports and Data

  Rising geriatric population and increasing incidences of age-related disorders are key factors expected to drive market growth.

  June 16, 2021

   · 

  6 min read
• Neglected Tropical Diseases Diagnosis Market to Reach USD 8.63 Billion in 2028, Noted Reports and Data

  Rising prevalence of neglected tropical diseases and increasing adoption of modern diagnostic services are key factors fueling global market growth.

  June 16, 2021

   · 

  5 min read
• DNA Microarray Market Size to Reach USD 8,677.7 Million in 2028, Noted Reports and Data

  Advancements in DNA microarray techniques, growing prevalence of various diseases, and increasing need for rapid and accurate diagnosis are key factors fueling global market growth

  June 16, 2021

   · 

  6 min read
• Sugar-based Excipients Market Size to Reach USD 1,542.5 Million in 2028, Noted Reports and Data

  Increasing use of co-processed excipients to improve dissolution, solubility, bioavailability of drugs, rising demand of generic oral prescribed medications, and technological advancements in sugar-based excipients are some key factors driving market growth.

  June 16, 2021

   · 

  5 min read
• Drug Development

  Sirnaomics Announces Acceptance of Investigational New Drug Application by China NMPA for Global Multicenter Phase 2b Trial of STP705 Treatment for Skin Squamous Cell Carcinoma

  Sirnaomics, Inc., today announced that the China National Medical Product Administration (NMPA) has accepted its Investigational New Drug (IND) application for the company’s lead candidate, STP705, for the treatment of skin squamous cell carcinoma in situ (isSCC).

  June 16, 2021

   · 

  6 min read
• Deals

  Verve Therapeutics Announces Pricing of Initial Public Offering

  Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the pricing of its initial public offering of 14,035,789 shares of its common stock at a price to the public of $19.00 per share

  June 16, 2021

   · 

  3 min read
• Healthcare Automatic Identification & Data Capture (AIDC) Market Size to Reach USD 74.6 Billion in 2028, Says Reports and Data

  Rapid expansion of the e-commerce industry globally is driving revenue growth of the market.

  June 16, 2021

   · 

  5 min read
• Wound Care Biologics Market Size to Reach USD 3.71 Billion in 2028, Says Reports and Data

  Rising incidence of diabetic foot ulcers, increasing rate of burn injuries, and growing geriatric population and high rate of injuries are some key factors driving market growth.

  June 16, 2021

   · 

  5 min read